DK175764B1 - Transplaceringsvektor omfattende genet for human nervevækstfaktor, insektceller inficeret med vektoren, fremgangsmåde til fremstilling af .......... - Google Patents

Transplaceringsvektor omfattende genet for human nervevækstfaktor, insektceller inficeret med vektoren, fremgangsmåde til fremstilling af .......... Download PDF

Info

Publication number
DK175764B1
DK175764B1 DK198903667A DK366789A DK175764B1 DK 175764 B1 DK175764 B1 DK 175764B1 DK 198903667 A DK198903667 A DK 198903667A DK 366789 A DK366789 A DK 366789A DK 175764 B1 DK175764 B1 DK 175764B1
Authority
DK
Denmark
Prior art keywords
hngf
vector
dna
baculovirus
biologically active
Prior art date
Application number
DK198903667A
Other languages
Danish (da)
English (en)
Other versions
DK366789A (da
DK366789D0 (da
Inventor
Hardy W Chan
Jim W Barnett
Preston A Baecker
Hela Bursztyn-Pettegrew
Binh T Nguyen
Carol Ward
Original Assignee
Roche Palo Alto Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto Llc filed Critical Roche Palo Alto Llc
Publication of DK366789D0 publication Critical patent/DK366789D0/da
Publication of DK366789A publication Critical patent/DK366789A/da
Application granted granted Critical
Publication of DK175764B1 publication Critical patent/DK175764B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DK198903667A 1988-11-22 1989-07-25 Transplaceringsvektor omfattende genet for human nervevækstfaktor, insektceller inficeret med vektoren, fremgangsmåde til fremstilling af .......... DK175764B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27487888A 1988-11-22 1988-11-22
US27487888 1988-11-22

Publications (3)

Publication Number Publication Date
DK366789D0 DK366789D0 (da) 1989-07-25
DK366789A DK366789A (da) 1990-05-23
DK175764B1 true DK175764B1 (da) 2005-02-14

Family

ID=23049976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903667A DK175764B1 (da) 1988-11-22 1989-07-25 Transplaceringsvektor omfattende genet for human nervevækstfaktor, insektceller inficeret med vektoren, fremgangsmåde til fremstilling af ..........

Country Status (13)

Country Link
US (1) US5272063A (de)
EP (2) EP0859056A3 (de)
JP (3) JP2515399B2 (de)
KR (1) KR100225052B1 (de)
AT (1) ATE167701T1 (de)
AU (1) AU629840B2 (de)
CA (1) CA1341131C (de)
DE (1) DE68928718T2 (de)
DK (1) DK175764B1 (de)
ES (1) ES2118057T3 (de)
IE (2) IE81110B1 (de)
NZ (1) NZ230096A (de)
ZA (1) ZA895661B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
IT1238348B (it) * 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
IT1239271B (it) * 1990-02-27 1993-10-01 Fidia Spa Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
DE4139000A1 (de) 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf
ATE206056T1 (de) * 1992-06-08 2001-10-15 Takeda Chemical Industries Ltd Therapeutisches agens für neutropenie
CA2104418A1 (en) * 1992-08-24 1994-02-25 Miguel A. Maestro Method of preparing hydrindane compounds and hydrindane-related compounds
US5859311A (en) * 1995-11-27 1999-01-12 University Of Kentucky Research Foundation Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use
ES2293662T3 (es) * 1996-11-15 2008-03-16 Genentech, Inc. Purificacion de neurotrofinas.
US6245564B1 (en) * 1997-01-23 2001-06-12 Cornell Research Foundation, Inc. Method for separating cells
US8263402B1 (en) 1998-10-19 2012-09-11 Cornell Research Foundation, Inc. Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
US20030211088A1 (en) * 2001-03-12 2003-11-13 Field Loren J. Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
AU2002327433A1 (en) * 2001-08-10 2003-02-24 Cornell Research Foundation, Inc. Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
US20040005301A1 (en) * 2002-02-12 2004-01-08 Goldman Steven A. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
US20130224797A1 (en) 2010-10-15 2013-08-29 Jcr Pharmaceuticals Co., Ltd. Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
CN108456681B (zh) * 2018-03-26 2019-10-11 江苏中新医药有限公司 高效表达重组人神经生长因子的基因组合
CN109628487A (zh) * 2018-12-21 2019-04-16 华南农业大学 一种利用转基因猪唾液腺制备人神经生长因子的方法
CN111500641A (zh) * 2020-05-13 2020-08-07 华南农业大学 转人神经生长因子基因猪的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
ATE78293T1 (de) * 1983-05-27 1992-08-15 Texas A & M Univ Sys Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
JPS61205485A (ja) * 1985-03-09 1986-09-11 Eiko Otsuka ヒト神経成長因子遺伝子セグメント
IE60285B1 (en) * 1985-12-18 1994-06-29 Microgenesys Inc Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
ES2008204A6 (es) * 1986-09-09 1989-07-16 Genetics Inst Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5082774A (en) * 1988-08-30 1992-01-21 The General Hospital Corporation Recombinant human nerve growth factor

Also Published As

Publication number Publication date
DE68928718T2 (de) 1998-10-29
ZA895661B (en) 1991-04-24
CA1341131C (en) 2000-10-31
EP0370171B1 (de) 1998-06-24
JP2515399B2 (ja) 1996-07-10
JPH02291270A (ja) 1990-12-03
KR900008039A (ko) 1990-06-02
IE980253A1 (en) 2000-02-23
JP2732556B2 (ja) 1998-03-30
IE892425L (en) 1990-05-22
EP0859056A2 (de) 1998-08-19
JPH07247300A (ja) 1995-09-26
EP0370171A3 (de) 1990-08-29
ATE167701T1 (de) 1998-07-15
EP0859056A3 (de) 1999-03-24
IE81110B1 (en) 2000-03-08
DK366789A (da) 1990-05-23
DK366789D0 (da) 1989-07-25
EP0370171A2 (de) 1990-05-30
AU3900989A (en) 1990-05-31
DE68928718D1 (de) 1998-07-30
JPH09235299A (ja) 1997-09-09
NZ230096A (en) 1992-08-26
AU629840B2 (en) 1992-10-15
KR100225052B1 (ko) 1999-10-15
US5272063A (en) 1993-12-21
ES2118057T3 (es) 1998-09-16

Similar Documents

Publication Publication Date Title
DK175764B1 (da) Transplaceringsvektor omfattende genet for human nervevækstfaktor, insektceller inficeret med vektoren, fremgangsmåde til fremstilling af ..........
Choi et al. Developmental regulation of β-globin gene switching
CA2137377C (en) Retinal pigmented epithelium derived neurotrophic factor
US7511009B2 (en) Retinal pigmented epithelium derived neurotrophic factor
CN110461368A (zh) 具有变异衣壳的腺相关病毒病毒体及其使用方法
JPH06217778A (ja) ヒトｍｋ遺伝子及び蛋白質の配列
JPH07509600A (ja) ニューロトロフィン−４発現に基づく治療および診断法
AU700610B2 (en) Mutants of the Rb and p53 genes and uses thereof
WO1997039133A1 (en) Novel neuronal cell growth factor
US20020164687A1 (en) Platelet-derived growth factor C, DNA coding therefor, and uses thereof
US6194175B1 (en) Nucleic acids encoding truncated forms of inhibitory kappa B protein
US5885831A (en) Nuclear localization factor associated with circadian rhythms
CA2170605C (en) Mutants of the rb and p53 genes and uses thereof
EP0444638A2 (de) Verfahren zur Expression des menschlichen Nervenwachstumsfaktors in Arthropoda frugiperda Zellen durch Infektion mit rekombinantem Baculovirus
US5766922A (en) Functional ligands for the axonal cell rcognition molecule contactin
CN107033249B (zh) sTie2融合蛋白、其载体及含有sTie2融合蛋白的药物组合物
KR930005917B1 (ko) 에리트로포이에틴의 제조방법
JPS62501010A (ja) エリトロポエチンの生産方法
CA2192738A1 (en) Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof
JPH07501934A (ja) Ｇｐａ神経栄養因子の製造
Acland Synthesis and subcellular fate of proteins encoded by the mouse int-2 (FGF3) gene
MXPA96006388A (es) Formas truncadas de la proteina inhibidora kappa b (i kappa b alfa), produccion recombinante de dicha proteina y sus usos

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK